首页> 外文期刊>Neurology: Genetics >Prevalence of spinocerebellar ataxia 36 in a US population
【24h】

Prevalence of spinocerebellar ataxia 36 in a US population

机译:在美国人群中脊髓小脑共济失调36的患病率

获取原文
       

摘要

Objective: To assess the prevalence and clinical features of individuals affected by spinocerebellar ataxia 36 (SCA36) at a large tertiary referral center in the United States. Methods: A total of 577 patients with undiagnosed sporadic or familial cerebellar ataxia comprehensively evaluated at a tertiary referral ataxia center were molecularly evaluated for SCA36. Repeat primed PCR and fragment analysis were used to screen for the presence of a repeat expansion in the NOP56 gene. Results: Fragment analysis of triplet repeat primed PCR products identified a GGCCTG hexanucleotide repeat expansion in intron 1 of NOP56 in 4 index cases. These 4 SCA36-positive families comprised 2 distinct ethnic groups: white (European) (2) and Asian (Japanese [1] and Vietnamese [1]). Individuals affected by SCA36 exhibited typical clinical features with gait ataxia and age at onset ranging between 35 and 50 years. Patients also suffered from ataxic or spastic limbs, altered reflexes, abnormal ocular movement, and cognitive impairment. Conclusions: In a US population, SCA36 was observed to be a rare disorder, accounting for 0.7% (4/577 index cases) of disease in a large undiagnosed ataxia cohort. Genetic cerebellar ataxia is a clinically heterogeneous disease that progressively destroys the cerebellum and consequently impairs balance and coordination in the affected individual. 1 The diagnosis of cerebellar ataxia can be challenging because there are more than 500 genes associated with either primary or secondary ataxia, and many affected families remain undiagnosed for decades. The introduction of unbiased genomic diagnostic testing methods, such as clinical exome sequencing, into the diagnostic evaluation has greatly improved time to diagnosis, 2 , 3 but is limited in its ability to detect certain forms of genetic mutation such as repeat expansion disorders. 4 , 5 The spinocerebellar ataxias (SCAs) are a diverse group of neurodegenerative disorders characterized by an autosomal dominant pattern of inheritance and cerebellar symptoms, currently consisting of at least 43 distinct clinical entities, of which 11 are repeat expansion disorders. 6 One of these conditions, spinocerebellar ataxia 36 (SCA36), is caused by a GGCCTG hexanucleotide repeat expansion in the first intron of the pre-mRNA processing gene, nucleolar protein 56 (NOP56). 7 Individuals with this disorder show progressive, late-onset, ataxic symptoms affecting limb, trunk, and/or gait stability. 7 To date, SCA36 prevalence has been reported in regions of Japan, 7 , 8 Spain, 9 France, 8 Germany, 8 and most recently, in China, 10 but its prevalence in the United States is undetermined. Through combined methods of exome sequencing, linkage analysis, and fluorescent repeat primed PCR (RP-PCR), we molecularly identified SCA36 in 4 index cases, representing less than 1% of the undiagnosed population at a tertiary referral ataxia center.
机译:目的:评估在美国一家大型三级转诊中心受脊髓小脑共济失调36(SCA36)影响的个体的患病率和临床特征。方法:对在三级转诊共济失调中心综合评估的577例未诊断的散发或家族性小脑共济失调患者进行了SCA36分子评估。重复引物PCR和片段分析用于筛选NOP56基因中重复扩增的存在。结果:三联体重复引物PCR产物的片段分析在4个索引病例中在NOP56的内含子1中鉴定出GGCCTG六核苷酸重复扩增。这4个SCA36阳性家庭包括2个不同的族裔:白人(欧洲)(2个)和亚洲人(日本[1]和越南人[1])。受SCA36影响的个体表现出典型的临床特征,步态共济失调,发病年龄在35至50岁之间。患者还患有共济失调或痉挛性肢体,反射改变,眼球运动异常和认知障碍。结论:在美国人群中,观察到SCA36是一种罕见疾病,占大量未确诊的共济失调队列中疾病的0.7%(4/577指数例)。遗传性小脑性共济失调是一种临床上的异质性疾病,会逐渐破坏小脑,从而损害受影响个体的平衡和协调性。 1 小脑性共济失调的诊断可能具有挑战性,因为与这两种疾病相关的基因超过500个原发性或继发性共济失调,许多受影响的家庭数十年来仍未得到诊断。将无偏基因组诊断测试方法(例如临床外显子组测序)引入诊断评估,可以大大缩短诊断时间, 2,3 ,但是其检测某些形式的基因突变的能力受到限制,例如 4,5 脊髓小脑共济失调(SCA)是一组神经退行性疾病,其特征是常染色体显性遗传和小脑症状,目前至少由43种不同的临床实体组成,其中11个是重复扩增疾病。 6 其中一种情况是脊髓小脑共济失调36(SCA36),是由前mRNA加工基因的第一个内含子中的GGCCTG六核苷酸重复扩增引起的,该蛋白是核仁蛋白56(NOP56)。 7 患有这种疾病的个体表现出进行性,迟发性共济失调症状,影响肢体,躯干和/或步态稳定性。 7 迄今为止,SCA36患病率已报告在日本, 7,8 西班牙, 9 法国, 8 德国, 8 等地区以及最近的地区中,在中国, 10 ,但在美国的流行率尚未确定。通过外显子组测序,连锁分析和荧光重复引物PCR(RP-PCR)的组合方法,我们在4个索引病例中分子鉴定了SCA36,这代表了三级转诊共济失调中心未诊断人群的不到1%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号